Milestone Pharmaceuticals Inc. Common Shares Share Price
NASDAQ: MISTHealthcare
Live Milestone Pharmaceuticals Inc. Common Shares Share Price Chart
O H L
Milestone Pharmaceuticals Inc. Common Shares Performance Overview
Days Range
▼
$0.91Low
$0.92High
Markets Today
| Previous Close | $0.92 |
|---|---|
| Open | $0.92 |
| Volume | 67,439 |
| Day's Range | $0.91 - $0.92 |
| 52W Range | $0.88 - $3.06 |
| Market Cap | $110.70 M |
Historical Performance
| 1M Returns | -14.06 |
|---|---|
| 3M Returns | -29.26 |
| 6M Returns | -45.91 |
| 1Y Returns | -52.84 |
| 5Y Returns | -84.28 |
| 10Y Returns | NA |
Milestone Pharmaceuticals Inc. Common Shares Fundamentals
| Market Cap | $110.70 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $1.55 M |
| ROE TTM | -2.30 |
| EPS TTM | $-0.69 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.08 |
| EBITDA | $-62.03 M |
| Profit Margin | -4078.78 |
| Market Cap | $110.70 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $1.55 M |
| ROE TTM | -2.30 |
| EPS TTM | $-0.69 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.08 |
| EBITDA | $-62.03 M |
| Profit Margin | -4078.78 |
Milestone Pharmaceuticals Inc. Common Shares Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $1.55 M | $238.00 K | $559.00 K |
| Gross Profit + | $0 | $0 | $0 | $1.55 M | $224.00 K | $527.00 K |
| Operating Income | -$20.52 M | -$12.53 M | -$11.83 M | -$17.26 M | -$23.66 M | -$25.63 M |
| EBITDA | -$20.50 M | -$12.50 M | -$11.80 M | -$17.22 M | -$23.61 M | -$25.57 M |
| Interest Expense | -$935.00 K | -$951.00 K | -$967.00 K | -$985.00 K | -$4.13 M | -$4.72 M |
| Depreciation | $27.00 K | $28.00 K | $25.00 K | $34.00 K | $56.00 K | $57.00 K |
| Income Before Tax | -$20.76 M | -$12.97 M | -$11.92 M | -$17.41 M | -$26.07 M | -$28.61 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$20.76 M | -$12.97 M | -$11.92 M | -$17.41 M | -$26.07 M | -$28.61 M |
| Net Profit Margin | - | - | - | -1126.07% | -10952.1% | -5118.78% |
Milestone Pharmaceuticals Inc. Common Shares Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $288.19 M | $288.26 M | $311.78 M | $352.62 M | $373.70 M | $384.99 M |
| Reserve & Surplus | -$388.31 M | -$401.27 M | -$413.19 M | -$430.60 M | -$456.67 M | -$485.28 M |
| Non-Current Liabilities | $108.12 M | $55.88 M | $112.37 M | $113.46 M | $192.39 M | $196.87 M |
| Current Liabilities | $12.96 M | $9.28 M | $10.52 M | $13.98 M | $20.94 M | $22.18 M |
| Total Liabilities | $121.08 M | $65.16 M | $122.90 M | $127.44 M | $213.33 M | $219.06 M |
| Fixed Assets | $176.00 K | $159.00 K | $136.00 K | $511.00 K | $500.00 K | $469.00 K |
| Current Assets | $60.48 M | $46.17 M | $86.67 M | $111.92 M | $192.25 M | $180.33 M |
| Total Assets | $61.88 M | $47.42 M | $87.75 M | $113.56 M | $193.73 M | $181.63 M |
Milestone Pharmaceuticals Inc. Common Shares Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$20.76 M | -$12.97 M | -$11.92 M | -$17.41 M | -$26.07 M | -$28.61 M |
| Operating Cash Flow | -$13.95 M | -$12.57 M | -$9.75 M | -$12.78 M | -$16.05 M | -$22.71 M |
| Investing Cash Flow | $33.58 M | $9.94 M | -$34.98 M | $2.70 M | -$80.03 M | $111.99 M |
| Financing Cash Flow | $140.00 K | $36.00 K | $48.92 M | $36.43 M | $94.35 M | $9.13 M |
| Change in Cash | $19.77 M | -$2.59 M | $4.19 M | $26.36 M | -$1.73 M | $98.41 M |
Milestone Pharmaceuticals Inc. Common Shares Return Calculator
The Milestone Pharmaceuticals Inc. Common Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,521
Invested Amount$10,000
Est. Returns$-8,479
About Milestone Pharmaceuticals Inc. Common Shares
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Popular Stocks
FAQs
What is the share price of Milestone Pharmaceuticals Inc. Common Shares today?
Milestone Pharmaceuticals Inc. Common Shares (MIST) share price as of September 18, 2026 is $0.89. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Milestone Pharmaceuticals Inc. Common Shares?
Yes, Indian Investors can invest in the Milestone Pharmaceuticals Inc. Common Shares (MIST) Share by opening an international trading account with Angel One.
How can I purchase Milestone Pharmaceuticals Inc. Common Shares shares in India?
Purchasing Milestone Pharmaceuticals Inc. Common Shares (MIST) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Milestone Pharmaceuticals Inc. Common Shares (MIST) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Milestone Pharmaceuticals Inc. Common Shares?
Yes, you can purchase fractional shares of Milestone Pharmaceuticals Inc. Common Shares (MIST) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Milestone Pharmaceuticals Inc. Common Shares?
The market capitalization of Milestone Pharmaceuticals Inc. Common Shares on September 18, 2026, is $110.70 M.
In which sector Milestone Pharmaceuticals Inc. Common Shares belongs?
Milestone Pharmaceuticals Inc. Common Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Milestone Pharmaceuticals Inc. Common Shares stocks?
In order to invest in Milestone Pharmaceuticals Inc. Common Shares (MIST) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
